The National Association of Chain Drug Stores’ comments calls electronic prescribing an important tool for improving patient health outcomes and combating the misuse, abuse, and diversion of controlled substances.
The National Association of Chain Drug Stores board of directors' virtual meeting with the administration and Congressional leaders centered on policies essential to COVID-19 response, as well as pharmacy reimbursement reforms.
AAM welcomed testimony in which U.S. Trade Representative Robert Lightizer said the free trade agreement currently being negotiated will not contain a provision requiring 10-years of biologic exclusivity.
The American Pharmacists Association will recommend actions driving short- and long-term strategies to eliminate racism, discrimination, injustice and the marginalization of individuals within the profession and communities that it serves.
To minimize the spread of COVID-19, industry organizations issued a joint statement outlining best practices for pharmacies and PBMs to follow for documenting signature-free delivery or pickup of prescriptions.
Steve Anderson, president and CEO of the National Association of Chain Drug Stores, responded to a recent Wall Street Journal editorial that he said ignores the role pharmacies and pharmacists play in patient health.
The National Community Pharmacists Association praised the Senate and President Trump's subsequent signing of a measure extending loan forgiveness from eight weeks to 24 weeks, or until the end of the year.